Lineage Cell Therapeutics, Inc. Share Price
NASDAQ: LCTXHealthcare
Live Lineage Cell Therapeutics, Inc. Share Price Chart
O H L
Lineage Cell Therapeutics, Inc. Performance Overview
Days Range
▼
$1.00Low
$1.02High
Markets Today
| Previous Close | $1.03 |
|---|---|
| Open | $1.02 |
| Volume | 248,892 |
| Day's Range | $1.00 - $1.02 |
| 52W Range | $1.00 - $2.09 |
| Market Cap | $270.61 M |
Historical Performance
| 1M Returns | -2.83 |
|---|---|
| 3M Returns | -14.88 |
| 6M Returns | -31.33 |
| 1Y Returns | -33.55 |
| 5Y Returns | -59.61 |
| 10Y Returns | NA |
Lineage Cell Therapeutics, Inc. Fundamentals
| Market Cap | $270.61 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $14.56 M |
| ROE TTM | -1.03 |
| EPS TTM | $-0.14 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 4.44 |
| EBITDA | $-21.08 M |
| Profit Margin | -436.47 |
| Market Cap | $270.61 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $14.56 M |
| ROE TTM | -1.03 |
| EPS TTM | $-0.14 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 4.44 |
| EBITDA | $-21.08 M |
| Profit Margin | -436.47 |
Lineage Cell Therapeutics, Inc. Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $1.50 M | $2.77 M | $3.68 M | $6.61 M | $1.73 M | $1.07 M |
| Gross Profit + | $1.50 M | $2.77 M | $3.68 M | $6.61 M | $1.73 M | $1.07 M |
| Operating Income | -$6.50 M | -$19.78 M | -$3.79 M | -$6.55 M | -$7.59 M | -$8.92 M |
| EBITDA | -$6.34 M | -$4.77 M | -$3.61 M | -$6.36 M | -$7.41 M | -$8.74 M |
| Interest Expense | $478.00 K | $0 | $0 | $0 | $405.00 K | $0 |
| Depreciation | $164.00 K | $15.01 M | $178.00 K | $186.00 K | $188.00 K | $187.00 K |
| Income Before Tax | -$4.14 M | -$30.36 M | -$29.75 M | -$4.39 M | -$4.79 M | $1.54 M |
| Income Tax Expense | $0 | $0 | $0 | -$5.28 M | $0 | $0 |
| Net Income + | -$4.14 M | -$30.36 M | -$29.75 M | $892.00 K | -$4.79 M | $1.54 M |
| Net Profit Margin | -275.83% | -1098.16% | -808.26% | 13.5% | -277.62% | 144.43% |
Lineage Cell Therapeutics, Inc. Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $489.31 M | $490.55 M | $494.18 M | $515.47 M | $529.66 M | $535.72 M |
| Reserve & Surplus | -$410.29 M | -$442.17 M | -$472.13 M | -$470.92 M | -$475.78 M | -$474.80 M |
| Non-Current Liabilities | $21.01 M | $32.93 M | $59.46 M | $57.87 M | $48.69 M | $38.41 M |
| Current Liabilities | $13.09 M | $10.76 M | $9.38 M | $11.37 M | $8.15 M | $8.02 M |
| Total Liabilities | $34.10 M | $43.69 M | $68.84 M | $69.24 M | $56.84 M | $46.42 M |
| Fixed Assets | $48.69 M | $33.95 M | $33.86 M | $34.27 M | $34.20 M | $34.22 M |
| Current Assets | $49.98 M | $43.84 M | $42.26 M | $59.16 M | $56.16 M | $52.97 M |
| Total Assets | $111.75 M | $90.80 M | $89.64 M | $112.58 M | $109.53 M | $106.22 M |
Lineage Cell Therapeutics, Inc. Cash Flow
Quarterly
| Dec 2025 | Dec 2025 | Mar 2026 | Mar 2026 | Jun 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | $892.00 K | $892.00 K | -$4.81 M | -$4.81 M | $1.57 M | $1.57 M |
| Operating Cash Flow | -$4.88 M | -$4.88 M | -$8.08 M | -$8.08 M | -$7.24 M | -$7.24 M |
| Investing Cash Flow | -$15.33 M | -$15.33 M | -$2.33 M | -$2.33 M | $3.96 M | $3.96 M |
| Financing Cash Flow | $20.38 M | $20.38 M | $5.56 M | $5.56 M | $4.47 M | $4.47 M |
| Change in Cash | $347.00 K | $347.00 K | -$4.85 M | -$4.85 M | $1.44 M | $1.44 M |
Lineage Cell Therapeutics, Inc. Return Calculator
The Lineage Cell Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$3,922
Invested Amount$10,000
Est. Returns$-6,078
About Lineage Cell Therapeutics, Inc.
Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline currently includes: OpRegen, OPC1, ReSonance, ILT1, RND1, PNC1, and LCT-CON. Its programs are based on its proprietary, in-house, cell-based manufacturing platform, which it call AlloSCOPE (Allogeneic, Scalable, Consistent, Off-the-shelf, Pluripotent Cell Engineering), and supported by its associated development, formulation, manufacturing, and delivery capabilities. The AlloSCOPE platform is a proprietary differentiation and production modality from which, a single, well-characterized pluripotent cell line can create a stable current Good Manufacturing Practice, master cell bank.
Popular Stocks
FAQs
What is the share price of Lineage Cell Therapeutics, Inc. today?
Lineage Cell Therapeutics, Inc. (LCTX) share price as of September 18, 2026 is $1.00. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Lineage Cell Therapeutics, Inc.?
Yes, Indian Investors can invest in the Lineage Cell Therapeutics, Inc. (LCTX) Share by opening an international trading account with Angel One.
How can I purchase Lineage Cell Therapeutics, Inc. shares in India?
Purchasing Lineage Cell Therapeutics, Inc. (LCTX) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Lineage Cell Therapeutics, Inc. (LCTX) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Lineage Cell Therapeutics, Inc.?
Yes, you can purchase fractional shares of Lineage Cell Therapeutics, Inc. (LCTX) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Lineage Cell Therapeutics, Inc.?
The market capitalization of Lineage Cell Therapeutics, Inc. on September 18, 2026, is $270.61 M.
In which sector Lineage Cell Therapeutics, Inc. belongs?
Lineage Cell Therapeutics, Inc. operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Lineage Cell Therapeutics, Inc. stocks?
In order to invest in Lineage Cell Therapeutics, Inc. (LCTX) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
